ライフサイエンスコーパス: blood serum

1 ed for the selective sensing of a protein in blood serum.

2 ements demonstrated by zinc determination in blood serum.

3 chemical tool for the clinical diagnosis of blood serum.

4 ar detection limit are possible in undiluted blood serum.

5 re-useable manner to the target in up to 50% blood serum.

6 blems when applied in complex fluids such as blood serum.

7 polymer (NIP) electrodes in both buffer and blood serum.

8 100 nM-100 muM in buffer and 1-100 muM human blood serum.

9 00 fmol of glycoprotein and 0.1 muL of human blood serum.

10 gical signature for SCZ can be identified in blood serum.

11 osidase concentrations in both PBS and human blood serum.

12 ntibodies directly in undiluted, unprocessed blood serum.

13 biological fluids such as fish extracts and blood serum.

14 teriorates rapidly when immersed directly in blood serum.

15 llenged with complex sample matrices such as blood serum.

16 ty when the sensor is challenged directly in blood serum.

17 both in buffer and in heat-inactivated human blood serum.

18 ke of the IF complex of vitamin B(12) to the blood serum.

19 directly in undiluted, otherwise unmodified blood serum.

20 mployment in complex sample matrices such as blood serum.

21 bility in both phosphate-buffered saline and blood serum.

22 clinical studies of cytokines, and (3) human blood serum.

23 d in complex, multicomponent samples such as blood serum.

24 and at clinically relevant concentrations in blood serum.

25 ples and complex biological mixtures such as blood serum.

26 in and potential interfering agents found in blood serum.

27 let-derived growth factor (PDGF) directly in blood serum.

28 well as the actin depolymerizing activity of blood serum.

29 ases by 27% for the same experiment in human blood serum.

30 complex, contaminant-ridden samples such as blood serum.

31 s typically found in clinical tests of human blood serum.

32 ane proteins and proteins contained in human blood serum.

33 on; it is one of the major mitogens found in blood serum.

34 bust detection of this bacterial pathogen in blood serum.

35 ed sensitivity of glucose detection in human blood serum.

36 of around 90% beyond 1pM and within 25nM in blood serum.

37 y measure antibodies in a drop of unmodified blood serum.

38 occur in the DSC profile of NSCLC patient's blood serum.

39 detection of alpha-amylase activity in human blood serum.

40 ers, in artificial gastric acid, and even in blood serum.

41 cting unknown quantities of amylase in human blood serum.

42 ans and against deployment in and reuse from blood serum.

43 s and the major protein, HSA, present in the blood serum.

44 in the complex matrix of filtered undiluted blood serum.

45 m the biochemically complex sample matrix of blood serum.

46 AI-2 in clinical samples such as saliva and blood serum.

47 ic proteins even in complex samples, such as blood serum.

48 n of abnormal HSA concentration in a control blood serum.

49 ing and adult brain and is also found in the blood serum.

50 from high mannose glycan isomers from human blood serum.

51 % vs 16% hydrolysis after 20 min), and human blood serum (30% vs 50% hydrolysis after 24 h).

52 Blood serum, a common cell culture medium component, is

53 ope exchange was shown to be stable in human blood serum after incubation at 37 degrees C for at leas

54 in both buffer and complex mixtures such as blood serum; after 15 rounds of selection with a structu

55 athological measures, including decreases in blood serum albumin infiltration.

56 ong endothelial cell chemotactic activity of blood serum, an activity that is markedly diminished in

57 uses, we conducted extensive hematologic and blood serum analyses on infected ferrets to identify lym

58 CE-UV/MALDI MS method required only 2 muL of blood serum and allowed the performance of the total IgE

59 Detection methods of antibiotic residues in blood serum and animal derived foods are of great intere

60 n and quantitation of antibiotic residues in blood serum and animal foodstuffs are of great significa

61 GF at 1 nM directly in undiluted, unmodified blood serum and at 50 pM (1.25 ng/mL) in serum-diluted 2

62 hocyte cell surface markers were measured in blood serum and cell fractions from asymptomatic infecte

63 ied for measuring adenosine concentration in blood serum and drug formulation samples.The herein desc

64 gnificantly the IL-17 and TNF-alpha level in blood serum and fluorescent imaging could enable us to d

65 ction and quantitation of chloramphenicol in blood serum and foodstuffs arse highly in demand.

66 ystems for analysis of real samples, such as blood serum and freshwater.

67 The accurate glucose determination in human blood serum and good recoveries achieved in spiked urine

68 tested by determination of glucose in human blood serum and nitrite in water based on addition/recov

69 irect detection of small molecule targets in blood serum and other complex matrices.

70 In this study, we employed blood serum and plasma samples collected from 29 subject

71 plex proteinaceous, real-world media such as blood serum and plasma, even diluted.

72 in complex, multicomponent samples, such as blood serum and soil.

73 Spiked human blood serum and unknown real serum samples were analyzed

74 ), SO4(2-), and NO3(-)) which are present in blood serum and urine and found to be almost no interfer

75 Quantitative data obtained for Seronorm blood serum and urine reference materials were in excell

76 nvestigated by the detection of NGAL in both blood serum and urine samples.

77 the determination of UA, Tyr and AP in human blood serum and urine samples.

78 nt metals (Al, Co, Cr, Mn, Ni, Ti, and V) in blood serum and urine.

79 ccess to conventional diagnostic matrices of blood, serum and others.

80 its of quantification of TCC were 5 ng/mL in blood/serum and 10 ng/mL in urine, respectively.

81 ferritin reserves in both the liver and the blood serum, and also did not induce negative alteration

82 teroidal components and peptidic hormones in blood serum, and cognitive and physical tests were perfo

83 ssium ions in aqueous solutions, human whole blood serum, and human whole blood.

84 lities of the radiopeptides were assessed in blood serum, and their distribution coefficient was dete

85 depletion of the IgG from the sample, human blood serum, and thereby facilitate enrichment of the ot

86 ase mismatch from perfect target directly in blood serum, and under ideal conditions, observe statist

87 Vs isolated from A-549 cells, SH-SY5Y cells, blood serum, and urine from a lung cancer mouse model.

88 ation, multiple sample types including whole blood, serum, and food.

89 The 100% agreement between whole blood, serum, and plasma CRAG LFA results demonstrates t

90 The method was demonstrated with blood, serum, and plasma spotted on specimen collection

91 B, the sensitivities of the ICT-1 with whole blood, serum, and plasma were 83, 65, and 70%, respectiv

92 llus PCR Initiative for the testing of whole blood, serum, and plasma.

93 on models and is also highly up-regulated in blood, serum, and tissue infection models, indicating a

94 ct analysis of illicit drugs in 4 muL of raw blood, serum, and whole urine.

95 hepatitis B virus, a nonenteric pathogen, is blood serum antibody titers against HBsAg.

96 We hypothesized that PCBs in human blood serum are consistent from year to year in people w

97 as casein, nonfat milk, egg yolk, and human blood serum, are used to explore its phosphopeptide enri

98 r the isolation of FAP from cell lysates and blood serum as well as for its detection by ELISA, Weste

99 ential of the platinum electrode immersed in blood serum because the measured value reflects the stat

100 salts and human blood samples (whole blood, blood serum, blood plasma, and formed elements) was real

101 -C Fort and Madopar, water, urine, and human blood serum) by the standard addition method.

102 he analysis of a reference material of human blood serum, by the spike and recovery trials with seawa

103 1.38 (1.32 to 1.44), respectively; for cord-blood serum C-peptide level above the 90th percentile, 1

104 ly diagnosed neonatal hypoglycemia, and cord-blood serum C-peptide level above the 90th percentile.

105 th increased birth weight and increased cord-blood serum C-peptide levels.

106 is of ascorbic acid and dopamine in aqueous, blood serum, cerebrospinal fluid, and pharmaceutical sam

107 trated here for N-glycans derived from human blood serum collected from a healthy individual and a br

108 Urine and blood serum, collected on the last day of exposure, were

109 multifunctional resin to remove interfering blood serum components, followed by (iii) detecting the

110 frequency; this concentration is typical of blood serum concentrations when the drug is utilized in

111 Also, they displayed higher levels of blood serum corticosterone, as well as decreased body we

112 The nanotube concentration in the blood serum decreased exponentially with a half-life of

113 titative measurements of N-linked glycans in blood serum, distinguishing breast cancer patients from

114 gue diagnosis in phosphate buffer saline and blood serum environments (up to the neat level).

115 wed markedly decreased survival in blood and blood serum ex vivo.

116 e area percentage of each fatty acid in cord blood serum from 12 infants born to control women (who c

117 ement with a glycomic investigation of whole blood serum from a much larger lung cancer cohort.

118 ple, a comparative study was conducted using blood serum from a small group of lung cancer patients a

119 We analyzed blood serum from children and their mothers from urban a

120 work provides a thermodynamic description of blood serum from patients diagnosed with Bence Jones mye

121 ection of human IgA deficiency in real human blood serum has been developed.

122 valuated using model glycoproteins and human blood serum (HBS) spotted on glass or Teflon slides.

123 mponent, CD4(+) cell count, concentration of blood serum HIV-1 RNA, and the presence of breast inflam

124 nderwent prostate biopsy and measurements of blood serum IGF-I, IGF-II, IGFBP-2, and IGFBP-3 obtained

125 x overlapping signals in (1)H NMR spectra of blood serum in a long-term study of caloric restriction

126 lective determination of tryptophan (TRP) in blood serum in the presence of tyrosine.

127 strategy to sense target molecules in human blood serum is achieved by immobilizing aptamers (APTs)

128 Blood serum is commonly used for clinical diagnostics be

129 Monitoring of myoglobin (Mb) in human blood serum is highly in demand for early diagnosis of a

130 ibiotic residues in animal derived foods and blood serum is of great interest.

131 Acid phosphatase activity in the blood serum is usually separated into tartrate-resistant

132 Compared to conventional analysis of blood serum, it offers the advantage of noninvasive coll

133 ricated using this DNA aptamer are stable in blood serum, its lower affinity pushes their detection l

134 no metabolites were detected in mouse urine, blood serum, kidney, and liver homogenates 30 min after

135 deal of interest in the correlation between blood serum levels and the severity of risk for cardiova

136 ation and meta-analyses for variation in the blood serum levels of 129 metabolites as measured by the

137 We investigated temporal trends of blood serum levels of 13 perfluorinated alkyl acids (PFA

138 Overall, females had higher blood serum levels of corticosterone.

139 ubsequently found significant differences in blood serum levels of glycine (P = 4.04 x 10(-6)) and se

140 IL-36gamma peripheral blood serum levels were found to be closely associated w

141 Doses were titrated to achieve initial drug blood serum levels within the therapeutic range in child

142 capture could be achieved in the presence of blood serum, making the assay amenable to the analysis o

143 can detect tobramycin in filtered undiluted blood serum, measuring concentrations down to 10 muM wit

144 esonance spectroscopy was used to profile 32 blood serum metabolites obtained (before and after contr

145 l was to determine the extent and pattern of blood serum monitoring of mood stabilizers in Medicaid p

146 f human serum glycoproteins, i.e., the human blood serum N-glycome, is both complex and constrained b

147 rial interaction with host tissues including blood serum, nasal secretions, and pulmonary surfactant.

148 Two hours after 2-NP administration, rat blood serum nitrate plus nitrite levels were approximate

149 The RP values were measured in blood serum of 63 apparently healthy subjects.

150 First, total IgE quantification in the blood serum of a milk allergic patient by the IACE-UV te

151 Additionally, blood serum of control patients (n = 10) was sequentiall

152 peptides that specifically increased in the blood serum of M. bovis-infected animals).

153 peptides that specifically increased in the blood serum of M. bovis-infected animals).

154 Monitoring of the RP in the blood serum of patients was performed as a noninvasive m

155 M activity in the lung tumor environment and blood serum of patients with non-small cell lung cancer

156 applicable to antibody purification from the blood serum of seven different mammalian species and for

157 agnetic resonance spectroscopy of peripheral blood serum of swine and patients undergoing angioplasty

158 he diazaborine formation can be performed in blood serum or cell lysates with minimal interference fr

159 -free affinity biosensors for diagnostics in blood serum or plasma samples.

160 ethod, a sample of biological fluid, such as blood serum or urine, is filtered through a 10,000 molec

161 ultrasound when suspended in aqueous media, blood serum, or diluted blood.

162 rgeted protein from a complex sample such as blood, serum, or cell lysate.

163 c immunoassay results using a single drop of blood, serum, or plasma.

164 ay achieves the determination of cortisol in blood serum over the range of clinical interest (1-60 mi

165 d with those of gadopentetate dimeglumine in blood serum phantoms at 1.5 T, 3 T, and 7 T.

166 Data suggest that POCTs of blood (serum, plasma, or whole blood) have the highest a

167 ion of nimesulide in real samples like human blood serum, plasma and urine samples as well as some ph

168 per handling and shipping were developed for blood, serum, plasma, FFPE, and fresh/frozen tissue.

169 lyzed and stratified by specimen type (whole blood, serum, plasma, or oral fluid) or test type (POCT

170 In particular, blood serum/plasma and diabetic urine samples contain hi

171 for routine NMR-based metabolomics of human blood serum/plasma and should be considered as an altern

172 Fortified human blood serum, protein digest and fractions collected afte

173 We explored cord blood serum proteins by profiling a UCB pool of 12 neona

174 analysis of changes in the heat capacity of blood serum proteins can provide an insight into patient

175 ntial scanning calorimetry (DSC) analysis of blood serum proteins could reveal the patient response t

176 Turnover of blood serum proteins is a vital function in mammals, but

177 advance current knowledge of the human cord blood serum proteome.

178 16 M. bovis proteins were discovered in the blood serum proteomics data sets.

179 zyme-based sensors will not function, and in blood serum: reflecting selectivity and robustness as a

180 , the measurement of redox potential (RP) in blood serum reflects the prooxidant-antioxidant balance

181 n detection in physiological buffers such as blood serum remains difficult due to Debye screening, no

182 Monitoring of blood serum RP was performed in 64 liver transplant pati

183 ays, was successfully evaluated using spiked blood serum sample obtaining excellent recovery values i

184 ructural isomers of N-glycans derived from a blood serum sample of a cancer patient were also analyze

185 cessfully evaluated by detection of DCF in a blood serum sample without interference from the sample

186 ly evaluated by the detection of OH-PCB in a blood serum sample.

187 ed by determination of epirubicin in a human blood serum sample.

188 ric flow system for glucose determination in blood serum samples after enzymatic reaction with glucos

189 ct extracellular DNA and proteins from human blood serum samples and deliver these to two separate ou

190 ped sensor was used to detect sialic acid in blood serum samples and the results were in good agreeme

191 he package is illustrated with a data set of blood serum samples from 7 diet induced obese (DIO) and

192 t the sensor was able to quantify cocaine in blood serum samples in the range of concentrations betwe

193 this reagent for quantification of ACY-1 in blood serum samples is also explored.

194 um of 9 uveal melanoma cell lines and in the blood serum samples of 24 mice with uveal melanoma xenog

195 was successfully applied to the analysis of blood serum samples of five different men and women with

196 employed for the estimation of uric acid in blood serum samples of healthy individuals.

197 medium of uveal melanoma cell lines and the blood serum samples of mice with uveal melanoma xenograf

198 lycomic profiling of N-glycans released from blood serum samples of patients with different esophagea

199 Peripheral blood serum samples of RA patients contained substantial

200 t in uveal melanoma cell cultures and in the blood serum samples of xenotransplanted mice, of healthy

201 he method was applied to (1)H NMR spectra of blood serum samples to demonstrate the selective identif

202 and reliable detection of free bilirubin in blood serum samples using human serum albumin (HSA) stab

203 In 24 patients, paired peripheral blood serum samples were available for analysis.

204 Blood serum samples were collected to monitor compliance

205 hment of glycoproteins from 1 muL volumes of blood serum samples, performed in triplicate for each le

206 249 confirmed NCC-positive and 401 negative blood serum samples, the sensitivity of the recombinant

207 Sensor was used to analyze glucose in blood serum samples.

208 NE in pharmaceutical formulations, urine and blood serum samples.

209 ethod was successfully tested by using human blood serum samples.

210 s was demonstrated in analyses of the spiked blood serum samples.

211 physiological levels of creatinine in human blood serum samples.

212 ully applied for the determination of Cys in blood serum samples.

213 e real samples such as drug, milk, honey and blood serum samples.

214 ns from model glycoproteins and pooled human blood serum samples.

215 ully used for detection of free bilirubin in blood serum samples.

216 oeconomic status were evaluated using direct blood serum sampling and ADOS.

217 ins against a target antigen (antibodies) in blood/serum (serodiagnosis).

218 form well even when challenged directly with blood serum, soil and other complex, multicomponent samp

219 ction directly in complex matrices including blood serum, soil, and foodstuffs.

220 on range needed for the analysis of clinical blood serum specimens.

221 t proved to be metabolically stable in human blood serum (t(1/2) 7 vs 1.5 h for ADP).

222 In addition, 7A was stable in human blood serum, t1/2 of 15 vs 1.5 h for ADP, and resisted h

223 However, in the presence of blood serum, the lowest detection limit is 209 +/- 10 pp

224 probe has also been tested on sample having blood serum to check the reliability of the sensor.

225 paring biosensors to detect glucose level in blood serum, urea level in urine solution, hemoglobin, i

226 for the analysis of codeine and morphine in blood serum, urine samples and pharmaceutical formulatio

227 pplied for the determination of PSA in human blood serum, urine, and forensic samples without any cro

228 microheterogeneity of C9 purified from human blood serum, using an integrative workflow combining hig

229 Of those blood serum variables that gave highly significant negat

230 ection of anti-PEG abs directly from diluted blood serum was achieved within 40 min.

231 e major polyphenol of red wine (catechin) in blood serum was also measured at the end of the study.

232 metric biosensor for the detection of CRP in blood serum was developed herein based on controlled and

233 aires and folate levels in maternal and cord blood serum was examined in relation to infant allergic

234 Interestingly, testosterone in the blood serum was higher in the PE-fed group (11.01+/-1.48

235 Here, the blood serum was sampled from 104 AAAD+ patients and 103

236 Using blood serum, we found similar dysregulation of miR-124-3

237 and 7, the concentrations of azithromycin in blood serum were 0.22 +/- 0.02, 0.08 +/- 0.02, and 0.04

238 d the kynurenine:tryptophan ratio in patient blood serum were determined for stage III NSCLC patients

239 types of dirt and leaves, coal fly ash, and blood serum, were analyzed quantitatively for dissolved

240 selective sensors for a specific analyte in blood serum, which contains a large number of proteins,

241 etection of 1.2 pg mL(-1) (42 fM) PSA in 25% blood serum, which is about ten times more sensitive tha

242 tection limit of 10 nM was found using human blood serum, which is well below the diagnostic cutoff p

243 ical and label-free biosensor for insulin in blood serum with a clinically relevant linear range and

244 lowed detection and quantification of HSA in blood serum with a sensitivity limit of 3 nM.

245 ncentrations but also of doing this in whole blood serum with interfaces that were, subsequently, reu

246 sfully demonstrated by the analysis of human blood serums with a certified CRP and CCP content.

247 sed by detection of STR in a spiked milk and blood serum without interference from the sample matrix.

248 tection directly in complex samples (such as blood serum) without the need for target modification, p